ZBTB16 overexpression led to inhibition of proliferation, migration, and invasion of breast cancer cells, reversal of the EMT process, blockage of the cell cycle in G2-M phase, and apoptosis of breast cancer cells in vitro. Here, ZBTB16 is linked to breast carcinoma.